|
|
|
|
Southern Roundup: Georgia Pharmacy Foundation Awards Scholarships
Georgia Pharmacy Foundation Awards Scholarships In October 2008, the Georgia Pharmacy Foundation presented the Carlton Henderson Scholarship, the Regina Baird Scholarships, and the Neil L.Pruitt, Sr. Entrepreneurial Scholarship to...
|
|
|
Orexigen Therapeutics, Inc. (OREX) Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and
SAN DIEGO, Jan.8 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX - News) today announced that the first of four Phase 3 trials of its lead investigational product Contrave (naltrexone sustained release (SR)/bupropion...
|
|
|
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Second
SAN DIEGO, Jan.8 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met...
|
|
|
Midwest Roundup: Nebraska Medicaid to Cover Counseling and
and Drugs for Tobacco Cessation Nebraska Medicaid, in early December, started covering counseling and certain drugs specifically approved to help clients quit using tobacco.Coverage will include up to two 90-day sessions during a 12-month...
|
|
|
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Second
SAN DIEGO, Jan.8 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met...
|
|
|
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Second
SAN DIEGO, Jan.8 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met...
|
|
|
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Second
- Company to host conference call to discuss results in more detail at 5:00 p.m.ET today - SAN DIEGO, Jan. 8 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. today announced that the first of four Phase 3 trials of its lead...
|
|
|
CRIX, Pfizer, Partners HealthCare and CDISC Exploring Ways to Improve Patient Safety
The Clinical Research Information eXchange (CRIX) International has announced their participation with Pfizer, Partners HealthCare and the Clinical Data Interchange Standards Consortium (CDISC) in the ASTER (Adverse Drug Event Spontaneous...
|
|
|
Development of a Quality-of-Life Questionnaire for Adults with Strabismus
Hatt SR et al.- The authors have developed a 20-item, patient-derived, HRQOL questionnaire specific for adults with strabismus, with subscales to assess psychosocial and function concerns. This 20-item, condition-specific...
|
|
|
Lazard Capital Markets: CYBX
Re: Below is a digest of a company note on CYBX by Sean Lavin, Sr.Vice President and Medical Technology Analyst at Lazard Capital Markets. Please contact Wendy Marx (Wmarx@marxcommunications.com or 203-445-2850) or Tom Mariam (Tom...
|
|
|
Therapeutics Update in Noninfectious Uveitis
Suttorp-Schulten MS, Rothova A.The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844-848. Forrester JV. Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of...
|
|
|
The Future of the Academic Ophthalmologist
FRANCO M.RECCHIA, MD BRIAN R. CARLSON, MBA PAUL STERNBERG, JR., MD In ancient Athens, the sacred grove of olive trees in which Plato gave his lessons was called the Akademia, and any place of learning has since become known as 'academic...
|
|
|
Natalie P. Bennett
ATTLEBORO, MASS.and PROSPECT HARBOR , 88, of Attleboro, Mass., formerly of Prospect Harbor, died Wednesday, Dec. 31, 2008, at the Golden Living Center, Attleboro, Mass. She was born Nov. 18, 1920, in Winchester, Mass., the daughter...
|
|
|
ASHP 2008 Literature Awards Highlight Pharmacists' Expanded Areas of I
Pharmacists are being recognized with this years American Society of Health-System Pharmacists (ASHP)Research and Education Foundation Literature Awards for their contributions to cancer research, medication reconciliation, cardiac...
|
|
|
If The S&P Closes Below S&P 920
Symbols: LVS, NYT, SQNM enter symbol enter search string Author Alerts by Email We never spam!I shall take a short term swim in these evil instruments called Ultrashorts. Sometimes I read the news on yahoo finance or wsj.com and just...
|
|
|
Can video mobile phones improve CPR quality when used for dispatcher assistance during simulated cardiac arres
Bolle SR et al.- Video communication is unlikely to improve telephone CPR significantly without proper training of dispatchers and when using dispatch protocols written for audio-only calls. Improved dispatch procedures and...
|
|
|
Roberta 'Bobbie' Elitia (Bush) Hamilton, 65, of Waynesboro, died on Sunday, Jan. 4, 2009, at Cancer Treatment
Roberta 'Bobbie' Elitia (Bush) Hamilton, 65, of Waynesboro, died on Sunday, Jan.4, 2009, at Cancer Treatment Centers of America in Philadelphia. She was the loving wife of Francis Hamilton. Born June 27, 1943, in East Stroudsburg, she...
|
|
|
Orexigen's obesity drug Contrave gets US patent
Orexigen Therapeutics, Inc, a biopharmaceutical company focused on the treatment of obesity, announced that the United States Patent and Trademark Office (USPTO) has issued a patent for what the company refers to as the 'Weber/Cowley methods...
|
|
|
Nuon Therapeutics Inc. Names Michael M. Kitt, M.D., Chief Medical Officer
- Nuon Therapeutics, Inc., a clinical stage biotechnology company focused on novel therapies for autoimmune and chronic inflammatory diseases and pain, today announced the appointment of Michael M.Kitt, M.D., to the position of Chief...
|
|
|
CRIX, Pfizer, Partners HealthCare and CDISC Exploring Ways to Improve Patient Safety
CRIX's New Service Will Leverage Electronic Medical Records and Enable Easier and More Accurate Reporting of Adverse Drug Events RESTON, Va.--(BUSINESS WIRE)--Jan 6, 2009 - The Clinical Research Information eXchange (CRIX) International...
|
|
|
USD Women Win at UC-Colorado Springs
COLORADO SPRINGS, COLO.The University of South Dakota women's basketball team had four players score in double figures to lead the Coyotes to a 66-58 victory over the University of Colorado-Colorado Springs on Monday night in the Lions...
|
|
|
WBK: Balanced Attack Helps USD Beat Lions
COLORADO SPRINGS, COLO.The University of South Dakota women's basketball team had four players score in double figures to lead the Coyotes to a 66-58 victory over the University of Colorado-Colorado Springs on Monday night in the Lions...
|
|
|
Efforts to Reduce Unnecessary Antibiotic Prescribing: Are They Worth It? A Best Evidence Review
Interventions to Reduce Unnecessary Antibiotic Prescribing.A Systematic Review and Quantitative Analysis Ranji SR, Steinman MA, Shojania KG, Gonzales R Med Care. 2008;46:847-862 The study that this review is based on was selected...
|
|
|
Johns Hopkins Brain Sciences Institute to Open at The Science + Technology Park at Johns Hopkins University Sc
BALTIMORE--(BUSINESS WIRE)--The Forest City-New East Baltimore Partnership (FCNEBP) announced that the Brain Sciences Institute of the (BSI) will locate at 855 North Wolfe Street, in the John G.Rangos, Sr., Building, within the...
|
|
|
BioEnergy announces specialty chemicals leadership team
Quincy, MA - BioEnergy International, LLC (BioEnergy), a science and technology leader in the development of biorefineries that produce specialty chemicals and biofuels from renewable resources, announced the addition of Dr.'s Cenan Ozmeral...
|
